procainamide (PROCAN SR, PROCANBID)
DISEASE AND DRUG FAMILY INFORMATION
Search results below include Disease and Drug Family Information where your selected drug
is a secondary subject of discussion.
Antipsychotic drugs, also called neuroleptic drugs or major tranquilizers, are properly and successfully used to treat serious psychotic mental disorders, the most common of which is schizophrenia. In younger adults, an alarming number of those with schizophrenia who could and often have previously benefited from antipsychotic drugs are not receiving them. They are seen, among other places, on the streets and in homeless shelters. In older adults, the problem is not underuse but, rather, gross overuse by people who are not psychotic.
DRUG AND DIETARY SUPPLEMENT PROFILES
A comprehensive review of the safety and effectiveness of this drug. If the drug is not a Do
Not Use product, information on adverse effects, drug interactions and how to use the
medication are included.
Search results below include Drug and Dietary Supplement Profiles where your selected
drug is a secondary subject of discussion.
-
We list theses drugs as Do Not Use drugs because they are no more effective than similar drugs and cause irregular heartbeat.
-
We list this drug as a Do Not Use drug because it causes severe rashes and may cause irregular heartbeat and liver damage.
WORST PILLS, BEST PILLS NEWSLETTER ARTICLES
Search results below include Worst Pills, Best Pills Newsletter Articles where your
selected drug is a secondary subject of discussion.
December 2011
Find out about 12 drugs that can interact with widely prescribed quetiapine -- 12 million prescriptions sold in 2010 -- to cause serious, sometimes fatal, heart arrhythmias.
June 2011
This article lists 355 drugs with names that are often confused with similar-sounding drug names. Find out what you can do to prevent getting the wrong drug.
May 2003
Stronger warnings have been added to the professional product label, or “package insert,” for the fluoroquinolone antibiotic gatifloxacin (TEQUIN) about possible heart rhythm disturbances and problems with blood sugar control. This drug was approved by the Food and Drug Administration (FDA) in October 2001 and its marketing brought to nine the number of fluoroquinolone antibiotics on the market.